- Home
- PVLA vs TCMD Comparison
PVLA vs TCMD Comparison
Compare PVLA & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- TCMD
- Stock Information
- Founded
- PVLA 2015
- TCMD 1995
- Country
- PVLA United States
- TCMD United States
- Employees
- PVLA N/A
- TCMD N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- PVLA Health Care
- TCMD Health Care
- Exchange
- PVLA Nasdaq
- TCMD Nasdaq
- Market Cap
- PVLA 249.2M
- TCMD 235.5M
- IPO Year
- PVLA N/A
- TCMD 2016
- Fundamental
- Price
- PVLA $25.92
- TCMD $9.96
- Analyst Decision
- PVLA Strong Buy
- TCMD Hold
- Analyst Count
- PVLA 7
- TCMD 3
- Target Price
- PVLA $46.29
- TCMD $16.00
- AVG Volume (30 Days)
- PVLA 129.2K
- TCMD 211.1K
- Earning Date
- PVLA 08-15-2025
- TCMD 08-04-2025
- Dividend Yield
- PVLA N/A
- TCMD N/A
- EPS Growth
- PVLA N/A
- TCMD N/A
- EPS
- PVLA N/A
- TCMD 0.66
- Revenue
- PVLA N/A
- TCMD $293,164,000.00
- Revenue This Year
- PVLA N/A
- TCMD $7.96
- Revenue Next Year
- PVLA N/A
- TCMD $8.53
- P/E Ratio
- PVLA N/A
- TCMD $15.15
- Revenue Growth
- PVLA N/A
- TCMD 5.96
- 52 Week Low
- PVLA $11.17
- TCMD $8.61
- 52 Week High
- PVLA $29.27
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- TCMD 43.95
- Support Level
- PVLA N/A
- TCMD $9.80
- Resistance Level
- PVLA N/A
- TCMD $10.32
- Average True Range (ATR)
- PVLA 0.00
- TCMD 0.30
- MACD
- PVLA 0.00
- TCMD 0.03
- Stochastic Oscillator
- PVLA 0.00
- TCMD 27.27
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.